Olink/OLK

$21.90

0.41%
-
1D1W1MYTD1YMAX

About Olink

Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.

Ticker

OLK

Sector

Technology

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Jon Heimer

Employees

582

Headquarters

Uppsala, Sweden
Website
olink.com

Olink Metrics

BasicAdvanced
$2.71B
Market cap
-
P/E ratio
-$0.15
EPS
-
Beta
-
Dividend rate

What the Analysts think about Olink

Analyst Ratings

Majority rating from 4 analysts.
Hold

Price Targets

Average projection from 4 analysts.
18.72% upside
High $26.00
Low $26.00
$21.90
Current price
$26.00
Average price target

Olink Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-4.08% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$44.1M
50%
Net income
$-1.8M
-78.05%
Profit margin
-4.08%
-85.37%

Olink Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 87.5%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.05
-$0.11
-$0.07
-$0.01
-
Expected
$0.01
-$0.12
-$0.10
-$0.08
$0.15
Surprise
525%
-8.33%
-32.69%
-87.5%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell Olink stock

Buy or sell Olink stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing